ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,897,000 | +53.8% | 50,700 | +2.0% | 0.14% | +52.8% |
Q1 2018 | $2,534,000 | -30.0% | 49,700 | -36.4% | 0.09% | -19.8% |
Q4 2017 | $3,622,000 | -12.9% | 78,100 | 0.0% | 0.11% | -36.9% |
Q3 2017 | $4,160,000 | -14.2% | 78,100 | 0.0% | 0.18% | +144.4% |
Q2 2017 | $4,851,000 | -8.4% | 78,100 | 0.0% | 0.07% | -14.3% |
Q1 2017 | $5,294,000 | +13.4% | 78,100 | +17.6% | 0.08% | +2.4% |
Q4 2016 | $4,669,000 | -11.4% | 66,400 | -10.6% | 0.08% | -11.8% |
Q3 2016 | $5,271,000 | +42.2% | 74,300 | -2.0% | 0.09% | +63.2% |
Q2 2016 | $3,707,000 | +54.5% | 75,800 | +100.0% | 0.06% | +42.5% |
Q1 2016 | $2,399,000 | -34.2% | 37,900 | +16.6% | 0.04% | -29.8% |
Q4 2015 | $3,646,000 | +78.6% | 32,500 | +53.3% | 0.06% | +62.9% |
Q3 2015 | $2,042,000 | – | 21,200 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |